Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenyang Enrikefon Pharmaceutical is a Chinese pharmaceutical enterprise specializing in the development and large-scale production of chemical drug products. Headquartered in the Shenyang Economic and Technological Development Zone, the company focuses on high-quality injectable formulations across several therapeutic areas, including anti-infectives and gastroenterology. Its commercial portfolio features essential generic medications such as cefathiamidine, cefuroxime sodium, and omeprazole sodium. The firm operates modern, GMP-certified manufacturing facilities designed to meet the rigorous standards of the domestic healthcare market. By integrating research and development with efficient manufacturing processes, Shenyang Enrikefon Pharmaceutical provides critical medical solutions to hospitals and clinics throughout China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenyang Enrikefon Pharmaceutical.